受强制性开放获取政策约束的文章 - Jacob B. Reibel了解详情
可在其他位置公开访问的文章：7 篇
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
EA Akbay, S Koyama, J Carretero, A Altabef, JH Tchaicha, ...
Cancer discovery 3 (12), 1355-1363, 2013
强制性开放获取政策： US National Institutes of Health
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor
CL Christensen, N Kwiatkowski, BJ Abraham, J Carretero, F Al-Shahrour, ...
Cancer cell 26 (6), 909-922, 2014
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression
C Xu, CM Fillmore, S Koyama, H Wu, Y Zhao, Z Chen, GS Herter-Sprie, ...
Cancer cell 25 (5), 590-604, 2014
强制性开放获取政策： US National Institutes of Health
Inhibition of KRAS-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
Z Zhu, AR Aref, TJ Cohoon, TU Barbie, Y Imamura, S Yang, SE Moody, ...
Cancer discovery 4 (4), 452-465, 2014
强制性开放获取政策： US National Institutes of Health
Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer
H Zhang, J Qi, JM Reyes, L Li, PK Rao, F Li, CY Lin, JA Perry, MA Lawlor, ...
Cancer discovery 6 (9), 1006-1021, 2016
强制性开放获取政策： US National Institutes of Health, German Research Foundation, Wellcome Trust
Autophagy inhibition dysregulates TBK1 signaling and promotes pancreatic inflammation
S Yang, Y Imamura, RW Jenkins, I Cañadas, S Kitajima, A Aref, ...
Cancer immunology research 4 (6), 520-530, 2016
强制性开放获取政策： US National Institutes of Health
Co-Clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in ALK-Rearranged Non–Small Cell Lung Cancer and Predict Strategies to Overcome …
Z Chen, E Akbay, O Mikse, T Tupper, K Cheng, Y Wang, X Tan, A Altabef, ...
Clinical Cancer Research 20 (5), 1204-1211, 2014
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定